| The Mode for End-Stage Liver Disease (MELD) score is now the criteria for allocation in liver transplantation for patients with end-stage liver disease. Although the score has been effective in the prediction of mortality in patients awaiting liver transplantation, its abilities to predict posttransplantation outcome need study. The aim of this study is to explore Pretransplantation MELD score in predicting short-term survival of patients with benign end-stage liver disease post liver transplantation.Methods We studied 1-month and 3-month patient survival in 135 adult patients who underwent liver transplantation between January 2001 and December 2004 in our hospital. The MELD score pretransplantation was recorded. We shared categories of their MELD score (≤20, 21 ~30, ≥30). In our study, we also compared urine volume (ml/h) of the alive patients during operation with the dead ones. Patients who underwent retransplantation for acute liver disease, biochemical results were deficient before operation or blood type did not match were excluded.Results We found only those patients with a MELD score of 30 or higher had a survival that was markedly lower than the rest. The urine volume (ml/h ) of survival patients during operation is obviously higher than the dead ones.Discusion In our single transplantation center experience, pretransplantation MELD score has influence on survival during the first 3 months after transplantation. But they do not have linear relation and there was a threshold in the MELD score beyond which mortality increases in such a fashion that might preclude transplantation. Survival of patients with a MELD score of 30 or higher was worse compared with patients with MELD score below 30. As a consequence, the ability of the MELD score to discriminate between patients who were dead or alive was uncompletely. The urine volume(ml/h Muring operation can predictsthe lesion of Kidney from the factors before and during operation. It also correlates to the risk of patients post-transplantation. |